Vahdam India explores majority stake sale at $250-300M valuation, taps global FMCG majors
Premium D2C tea and wellness brand Vahdam India is exploring a majority stake sale at a $250-300 million valuation. Rothschild is running the process, sounding out global FMCG majors and Indian consumer firms like Mankind Pharma as potential strategic acquirers. Backers include Fireside, Sixth Sense and IIFL AMC.
What happened
Premium D2C tea and wellness brand Vahdam India is exploring a majority stake sale at a $250-300 million valuation. Rothschild is running the process, tapping
Key facts
- $250-300 million valuation
- Rs 174 crore Series D 2022
- 100+ countries
Why this matters
With global FMCG majors and Mankind Pharma circling, this is a live opportunity to acquire a built-out premium tea export platform — diligence should focus on US/EU channel concentration and category margin durability.